Anamik Shah
About
In The Last Decade
Anamik Shah
143 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 111
- Organic Chemistry 2.6k
- Molecular Biology 963
- Pharmacology 357
- Oncology 216
- Infectious Diseases 171
Countries citing papers authored by Anamik Shah
This map shows the geographic impact of Anamik Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anamik Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anamik Shah more than expected).
Fields of papers citing papers by Anamik Shah
This network shows the impact of papers produced by Anamik Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anamik Shah. The network helps show where Anamik Shah may publish in the future.
Co-authorship network of co-authors of Anamik Shah
This figure shows the co-authorship network connecting the top 25 collaborators of Anamik Shah. A scholar is included among the top collaborators of Anamik Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anamik Shah. Anamik Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 18 | |
| 6 | 13 | |
| 7 | 9 | |
| 8 | 5 | |
| 9 | Stress study and estimation of a potent anticoagulant drug rivaroxaban by a validated HPLC method: Technology transfer to UPLC | 8 |
| 10 | Chromatography method transfers from HPLC to a new generation instrument UPLC and studies on force degradation behavior of deflazacort | 1 |
| 11 | 11 | |
| 12 | 24 | |
| 13 | 16 | |
| 14 | 34 | |
| 15 | 12 | |
| 16 | 171 | |
| 17 | 28 | |
| 18 | Synthesis and antimicrobial screening of some arylaminocoumarins | 1 |
| 19 | 185 | |
| 20 | 17 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.